Skip to main content
Premium Trial:

Request an Annual Quote

Gabor Bethlendy, Nick Lazaridis

Premium
BioForce Nanosciences has named Gabor Bethlendy sales manager for Europe. He will be based in Boston, Mass.
 
Bethlendy joins BioForce from CombiMatrix, where he was regional sales manager for the company’s custom microarray and array synthesizer product lines. Prior to that, Bethlendy was senior application scientist for Agilent Technologies.
 

 
Gene Express has appointed Nick Lazaridis as president.
 

Lazaridis most recently served as senior vice president of preclinical services at AAI Pharma. Prior to that, he was senior vice president of laboratory services for AAI Development Services.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.